Ovarian Cancer Research Review, Issue 37
In this issue:
Artificial intelligence model may improve diagnosis of early-stage ovarian cancer
Four-biomarker panel detects early ovarian cancer up to 18 months earlier
Monitoring CA-125 level alone does not reliably detect progression of recurrent disease
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer
Fertility-sparing surgery safe for stage I endometrioid epithelial and mucinous ovarian cancer
SCRS plus olaparib maintenance for BRCA-mutated recurrent ovarian cancer
Surgical outcomes after SCRS in low- vs high-grade serous ovarian cancer
Interval debulking surgery feasible for advanced-stage ovarian yolk sac tumour
Anticoagulation for VTE safe during neoadjuvant chemotherapy
Survival with olaparib vs niraparib maintenance for BRCA-mutated disease
Expert contributor
Dr Rhett Morton
Dr Rhett Morton is a sub-specialist Gynaecological Oncologist based in Brisbane at the Mater public and Wesley private hospitals. He is a senior lecturer at University of Queensland Centre for Clinical Research and has interests in regional and global health equity, surgical training and observational research methodology.
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.